Eusol Biotech Co.,Ltd. (TPEX:6652)
Taiwan
· Delayed Price · Currency is TWD 6.56
+0.21 (3.31%)
Mar 10, 2026, 1:46 PM CST
Eusol Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -37.78 | -30.55 | -51.61 | -18.31 | -123.31 | -113.77 | Upgrade
|
| Depreciation & Amortization | 3.38 | 3.5 | 4.03 | 23.11 | 28.06 | 29.21 | Upgrade
|
| Other Amortization | 0.02 | - | - | 0.08 | 0.16 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.99 | -0.21 | -0.04 | -108.66 | - | -0.12 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 51.58 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 12.45 | - | 2 | - | Upgrade
|
| Stock-Based Compensation | - | - | - | - | - | 0.55 | Upgrade
|
| Other Operating Activities | -0.43 | -2.76 | -6.86 | 6.16 | -0.06 | 0.48 | Upgrade
|
| Change in Accounts Receivable | -1.21 | -1.12 | -4.59 | -2.36 | 0.01 | -1.91 | Upgrade
|
| Change in Accounts Payable | 0.68 | 0.58 | -1.86 | -8.85 | 3.89 | -1.93 | Upgrade
|
| Change in Other Net Operating Assets | 1.24 | -1.53 | 5.44 | 4.36 | 0.37 | -2.68 | Upgrade
|
| Operating Cash Flow | -35.09 | -32.09 | -43.03 | -52.88 | -88.89 | -89.96 | Upgrade
|
| Capital Expenditures | -1.05 | -0.91 | -0.07 | - | -0.56 | -1.63 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.15 | 0.43 | 1.11 | 171.64 | - | 0.16 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.09 | -0.09 | -0.04 | -0.08 | -0.08 | -0.15 | Upgrade
|
| Investment in Securities | 14.7 | 70.1 | 112.87 | -220.6 | -30 | 16.21 | Upgrade
|
| Other Investing Activities | -0.67 | -0.04 | - | 0.42 | - | - | Upgrade
|
| Investing Cash Flow | 14.03 | 69.49 | 113.87 | -48.63 | -30.64 | 14.59 | Upgrade
|
| Long-Term Debt Repaid | - | -2.44 | -2.44 | -3.43 | -4.78 | -4.76 | Upgrade
|
| Net Debt Issued (Repaid) | -2.44 | -2.44 | -2.44 | -3.43 | -4.78 | -4.76 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 300 | - | Upgrade
|
| Financing Cash Flow | -2.44 | -2.44 | -2.44 | -3.43 | 295.22 | -4.76 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0.64 | 1.51 | -0.44 | -0.91 | Upgrade
|
| Net Cash Flow | -23.49 | 34.96 | 69.04 | -103.43 | 175.25 | -81.05 | Upgrade
|
| Free Cash Flow | -36.14 | -32.99 | -43.1 | -52.88 | -89.45 | -91.59 | Upgrade
|
| Free Cash Flow Margin | -9768.65% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.26 | -0.24 | -0.32 | -0.39 | -0.67 | -0.73 | Upgrade
|
| Cash Interest Paid | - | - | 0 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 0.43 | 0.31 | 9.38 | - | -0.03 | -0 | Upgrade
|
| Levered Free Cash Flow | -25.38 | -28.14 | -30.1 | -25.96 | -43.5 | -49.22 | Upgrade
|
| Unlevered Free Cash Flow | -25.35 | -28.09 | -30.01 | -25.83 | -43.36 | -49.13 | Upgrade
|
| Change in Working Capital | 0.7 | -2.06 | -1 | -6.84 | 4.27 | -6.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.